Rituximab therapy for primary glomerulonephritis: Report on two cases

doi:10.12998/wjcc.v3.i8.736

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8644)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

559

WORD

401

HTML

4560

Figures (1-2)

276

Tables (1-3)

236

Sum=6032

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1137

Download

1475

Sum=2612

Aug 16, 2015 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 16, 2015; 3(8): 736-742
Published online Aug 16, 2015. doi: 10.12998/wjcc.v3.i8.736

Full Size Figure Download Figure

Figure 2 Biochemical/serological response to therapy (patient 1). HD: Haemodialysis; MP: High-dose methylprednisolone; PEX: Plasma-exchange; RTX: Rituximab.

Citation: Fabrizi F, Cresseri D, Fogazzi GB, Moroni G, Passerini P, Martin P, Messa P. Rituximab therapy for primary glomerulonephritis: Report on two cases. World J Clin Cases 2015; 3(8): 736-742
URL: https://www.wjgnet.com/2307-8960/full/v3/i8/736.htm
DOI: https://dx.doi.org/10.12998/wjcc.v3.i8.736